Endocrinology Target Series: Type 1 Diabetes (T1D)

Navigate the Complex Landscape of T1D Targets

Report
T1D is a chronic autoimmune disease with no cure. Effective management demands daily insulin doses, regular blood sugar monitoring, and lifestyle modifications.
Identifying novel targets is crucial for pioneering more efficient T1D treatments and alleviating patient burdens. But with over 100,000 publications on T1D in PubMed, searching for therapeutic targets is challenging, time-consuming and subject to bias.
What you'll get with our first endocrinology target series:
  • Target Landscape: Around 2,000 Targets for T1D
  • Genomic Insights: Targets with GWAS data
  • Animal Models: Including studied in mice and rats
  • Targets in Clinical Studies: Targets in clinical trial publications
  • 2023 Insights: Emerging targets studied this year

Request your copy of
Endocrinology Target Series: Type 1 Diabetes (T1D)

Fill out the form below to access the full report.

‌